ITEMS IN AFP WITH KEYWORD:

Heart Disease

Oct 15, 2016 Issue
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendation Statement [U.S. Preventive Services Task Force]

The USPSTF recommends initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectal cancer (CRC) in adults aged 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, ...


Jun 15, 2016 Issue
Rapid Protocols to Rule out Myocardial Infarction [Point-of-Care Guides]

Cardiac troponin T and I are released into the bloodstream when cardiac muscle is damaged. Cardiac troponin tests have been available for decades and are the preferred biomarkers for the diagnosis of acute myocardial infarction (AMI). However, until recently, they lacked sensitivity in the first few hours following an acute myocardial injury.


Jun 1, 2016 Issue
Diet and Physical Activity for Cardiovascular Disease Prevention [Article]

Learn which diet and physical activity strategies have the best supporting evidence to prevent the leading causes of death in the United States.


Apr 15, 2016 Issue
Low High-Sensitivity Troponin I Level Accurate in Identifying Patients at Low Risk of Cardiac Events [POEMs]

The high-sensitivity troponin I assay used in this study was fairly accurate in identifying patients with chest pain who are at low risk of cardiac events.


Mar 1, 2016 Issue
In Patients with Type 2 Diabetes and CV Disease, Empagliflozin Reduces CV and All-Cause Mortality [POEMs]

In patients with established CV disease and type 2 diabetes, the addition of empagliflozin to standard therapy reduces all-cause mortality and CV mortality. This is notable because empagliflozin is the only drug other than metformin to demonstrate a mortality benefit, albeit for a fairly narrow group of patients.


Mar 1, 2016 Issue
Influenza Vaccination for the Prevention of Cardiovascular Disease [Cochrane for Clinicians]

Influenza vaccination may reduce cardiovascular mortality in patients with established cardiovascular disease. The effect of vaccination is unclear among patients in the general population without known cardiovascular disease.


Feb 1, 2016 Issue
Preventing CVD in Adults with Type 2 Diabetes Mellitus: An Update from the AHA and ADA [Practice Guidelines]

The American Heart Association (AHA) and American Diabetes Association (ADA) joined together to release statements on preventing CVD in persons with diabetes.


Jan 1, 2016 Issue
More Nuanced Guidelines for Lipid Lowering to Prevent CVD [POEMs]

The authors of this guideline give a more nuanced and less aggressive approach to lipid lowering than other groups. For the primary prevention of CVD, check blood pressure and lipids (nonfasting is fine) to calculate the 10-year CVD risk. If greater than 12%, treat; if 12% or less, discuss treatment with the patient.


Nov 15, 2015 Issue
CT Coronary Angiography in Patients with Suspected CAD: No Short-Term Benefit, Increased Rate of Invasive Angiography [POEMs]

For patients with suspected stable CAD, adding CT coronary angiography had no short-term effect on patient symptoms or hospitalizations but increased the number of coronary angiograms. Additionally, more patients who had CT coronary angiography underwent preventive treatment and anti-anginal treatment.


Sep 15, 2015 Issue
ECG, Echocardiography, or MPI for Cardiac Screening: Guidance from the ACP [Practice Guidelines]

In the United States, one in three deaths is from cardiovascular disease; coronary heart disease is the leading cause of death. This guideline from the American College of Physicians (ACP) provides recommendations on cardiac screening using these modalities.


Pages: Previous 1 2 3 4 5 6 7 8 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now